NCT01567111View on ClinicalTrials.gov

11C-Metomidate PET Versus Adrenal Vein Sampling in Primary Aldosteronism

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

August 31, 2015

Study Completion Date

March 31, 2019

Conditions
Primary Hyperaldosteronism
Interventions
PROCEDURE

11C-Metomidate Positron Emission Tomography

Dose of intravenous 11C-Metomidate injection is 440MBq and emission scanning of upper abdomen. PET/CT imaging will be done using the Discovery PET/CT VCT or 690 scanner (General Electric Medical Systems, Milwaukee, WI, USA)

Trial Locations (3)

Unknown

Helsinki University Central Hospital, Helsinki

Tampere University, Tampere

University of Turku, Turku

All Listed Sponsors
collaborator

Turku University Hospital

OTHER_GOV

collaborator

Tampere University

OTHER

lead

Helsinki University Central Hospital

OTHER

NCT01567111 - 11C-Metomidate PET Versus Adrenal Vein Sampling in Primary Aldosteronism | Biotech Hunter | Biotech Hunter